Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance

Clinical trial NCT06483100 · RECRUITING

Trial details

NCT number: NCT06483100
Sponsor: Washington University School of Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2024-12-20
Primary completion: 2032-06-30
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.